Non-surgical treatment of vestibular schwannoma patients

Acta Otolaryngol Suppl. 1997:529:56-8. doi: 10.3109/00016489709124080.

Abstract

The aim of the study was to evaluate the course of vestibular schwannoma (VS) when surgery was not attempted. The tumor may be slowly growing and surgery a risk for a patient. Twenty-eight patients out of 390 VS patients during years 1981-1995 were primarily recommended a non-surgical treatment. Another 3 patients refused the operation. Altogether 23 women and 8 men were evaluated. Their age varied from 30.6 to 74.6 years (median 56.7 years). Tumor size varied from 5 to 30 mm (median 15.0 mm) at the beginning of the follow-up. Patients symptoms, condition and other illnesses were recorded. Seven patients had neurofibromatosis 2 (3 of them had one hearing ear), 2 had severe mental problems, 5 patients had their only hearing ear and 11 patients were not recommended an operation because of their age and other illnesses. Patients were controlled with MRI at intervals from 1 to 3 years. The follow-up time varied from 1 to 20 years (median 2.0 years). The average tumor growth rate among unilateral VS patients was 0.035 cm/year and among bilateral tumors the average tumor growth rate was 0.015 cm/year. Two patients were later operated on, one 2 years after diagnosis because of the tumor growth and the other one 4 years after diagnosis-she had refused an operation earlier. Two patients could not be reached. Another patient had tumor growth but because of his illnesses he got a radiation beam instead of an operation. The majority of the patients could live fairly normal lives and required no treatment. Surgery is not the only alternative to VS patients. Wait-and-see policy is also a good alternative to those who have high operation risk or who refuse an operation.

MeSH terms

  • Adult
  • Age Factors
  • Aged
  • Disease Progression
  • Female
  • Follow-Up Studies
  • Humans
  • Magnetic Resonance Imaging
  • Male
  • Middle Aged
  • Neuroma, Acoustic / diagnosis
  • Neuroma, Acoustic / epidemiology
  • Neuroma, Acoustic / therapy*
  • Time Factors
  • Treatment Refusal